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Abstract
DNA double-strand breaks are a feature of many acute and long-term neurological 
disorders, including neurodegeneration, following neurotrauma and after stroke. 
Persistent activation of the DNA damage response in response to double strand 
breaks contributes to neural dysfunction and pathology as it can force post-mitotic 
neurons to re-enter the cell cycle leading to senescence or apoptosis. Mature, non-
dividing neurons may tolerate low levels of DNA damage, in which case muting the 
DNA damage response might be neuroprotective. Here, we show that attenuating the 
DNA damage response by targeting the meiotic recombination 11, Rad50, Nijmegen 
breakage syndrome 1 complex, which is involved in double strand break recognition, 
is neuroprotective in three neurodegeneration models in Drosophila and prevents A1-
42-induced loss of synapses in embryonic hippocampal neurons. Attenuating the DNA 
damage response after optic nerve injury is also neuroprotective to retinal ganglion 
cells and promotes dramatic regeneration of their neurites both in vitro and in vivo. 
Dorsal root ganglion neurons similarly regenerate when the DNA damage response is 
targeted in vitro and in vivo and this strategy also induces significant restoration of lost 
function after spinal cord injury. We conclude that muting the DNA damage response 
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3in the nervous system is neuroprotective in multiple neurological disorders. Our results 
point to new therapies to maintain or repair the nervous system.
Key words: DNA damage, neurodegeneration, neuroprotection, CNS trauma, spinal 
cord injury.
Running title: Attenuating DNA damage is neuroregenerative
Abbreviations
AD = Alzheimer’s disease; ATM = ataxia telangiectasia mutated; ATR = ataxia 
telangiectasia and Radiation 3-related protein; BSA = bovine serum albumin; cAMP = 
cyclic adenosine monophosphate; CAP = compound action potential; CME = CNS 
myelin extracts; CMV = cytomegalovirus; CNTF = ciliary neurotrophic factor; Cy3 = 
cyanine 3; DAPI = 4',6-diamidino-2-phenylindole; DC = dorsal column; DMEM = 
Dulbecco’s modified Eagle’s medium; DMSO = dimethyl sulfoxide; DN1 = dorsal 
neuron 1; DN2 = dorsal neuron 2; DRG = dorsal root ganglion; DRGN = dorsal root 
ganglion neurons; FBS = foetal bovine serum; FGF2 = fibroblast growth factor 2; 
GAP43 = growth associated protein 43; GLMM = generalised linear mixed models; HD 
= Huntington’s disease; HRP = horseradish peroxidase; IC50 = half maximum inhibitory 
concentration; IgG = Immunoglobulin; lLNv = large lateral neuron ventral; LMM = linear 
mixed models; LNd = lateral neuron dorsal; Mre11 = meiotic recombination 11; MRN 
complex = meiotic recombination 11/Radiation 50/Nijmegen breakage syndrome 1 
complex; Nbs1 = Nijmegen breakage syndrome 1; NF = neurofilament; ONC = optic 
nerve crush; PAGE = polyacrylamide gel electrophoresis; PBS = phosphate buffered 
saline; PDF = pigment dispersing factor; PFA = paraformaldehyde; P/S = 
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4penicillin/streptomycin; PTEN = phosphatase and tensin homolog; RGC = retinal 
ganglion cells; Rad50 = Radiation 50; RT = room temperature; SCI = spinal cord injury; 
SDS = sodium dodecyl sulphate; shRNA = short hairpin RNA; siCASP2 = short 
interfering RNA to caspase-2; sLNv = small lateral neuron ventral; TBS = Tris buffered 
saline; UAS = upstream activation sequence. 
Introduction
DNA double-strand breaks are the most deleterious type of DNA damage. In mitotically 
cycling cells, double strand breaks trigger the DNA damage response to arrest the cell 
cycle in and mount repair via non-homologous end-joining in G1 or G2 phases or 
homologous recombination in M and S phases (Mladenov et al., 2016). Double strand 
breaks are a feature of many acute and long-term neurological disorders, including 
many forms of neurodegeneration (Simpson et al., 2015; Merlo et al., 2016), following 
neurotrauma (Kotipatruni et al., 2011) and after stroke (Hayashi et al., 1998). 
Unrepaired double strand breaks in neurons leads to persistent activation of the DNA 
damage response which, in turn, is a trigger for dysregulation of the cell cycle and 
aberrant re-entry of neurons into G1 leading to neural dysfunction, apoptosis and 
senescence (Herrup et al., 2004). Re-entry of neurons into the cell cycle and 
senescence are features of Alzheimer’s disease (McShea et al., 1997; Nagy et al., 
1997; Fielder et al., 2017) whilst dysfunctional regulation of the cell cycle and has also 
been documented in models of cerebral ischemia (Katchanov et al., 2001; Wen et al., 
2004) and in post-mortem brain samples of stroke patients (Love, 2003).
If persistent activation of the DNA damage response is a trigger for neuronal 
dysfunction, apoptosis and senescence then potentially muting the DNA damage 
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5response would be neuroprotective. A key sensor and early processor of double strand 
breaks is the MRN complex, comprising the Mre11, Rad50 and Nbs1/Nbn proteins 
(Lamarche et al., 2010). Association of the MRN complex to double strand breaks 
leads to recruitment and activation of the ataxia telangiectasia mutated (ATM) kinase, 
which coordinates multiple arms of the DNA damage response, including cell-cycle 
arrest, repair and apoptosis (Shiloh and Ziv, 2013). ATM activation is particularly 
associated with non-homologous end-joining; in contrast, the related kinase, ataxia 
telangiectasia and Rad3-related (ATR) protein, regulates homologous recombination. 
Double strand breaks are characterised by the activation of sensor kinases, including 
DNA-protein kinase catalytic subunit and regions of DNA damage incorporating 
phosphorylated histone H2Ax (Shrivastav et al., 2008). Therefore, H2Ax is 
commonly used to monitor direct activation of the DNA damage response in terms of 
double strand breaks (Celeste et al., 2002; Simpson et al., 2015; Milanese et al., 
2018). ATM is recruited at the site of lesions such as double strand breaks to 
phosphorylate in cis the histone H2Ax (H2Ax) (Celeste et al., 2002). H2Ax marks the 
initiation of a nucleation process resulting in the formation of characteristic H2Ax+ 
nuclear foci, which leads to additional ATM recruitment at the damage site, thereby 
escalating the kinase activity (Shiloh and Ziv, 2013). 
In post-mitotic neurons, homologous recombination is unlikely to feature in the 
repair of double strand breaks as no sister chromatid is available to act as a template 
for repair. Given its position at the apex of the DNA damage response, the MRN 
complex is a potential target to attenuate or mute the DNA damage response in 
neurons. Here, we targeted the MRN complex using both genetic approaches in 
Drosophila models of neurodegeneration and using small-molecule inhibitors in two 
rat models of acute neurotrauma: ocular injury and spinal cord injury. We identified 
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6that targeting of the MRN complex was neuroprotective in each scenario. This 
universality opens up new possibilities for treating human neurological disorders. 
Materials and Methods
Drosophila stocks and breeding 
For all Drosophila experiments except circadian analysis, expression of the 
neurodegeneration-associated transgenes was restricted to adult neurons by use of 
an elavC155; GAL80ts driver line. Drosophila were bred on standard yeast/agar media 
in bottles at 18°C on a 12 h light/dark cycle until eclosion. To induce expression, flies 
were shifted to and maintained at 29°C, 70% humidity on a 12 h light/dark cycle for 
the duration of the experiment. Virgin females of the driver line were crossed to males 
of the control or experimental lines. The control used was an isogenic w1118 strain and 
all experimental lines were backcrossed over 5 generations into this line. UAS-lines 
and the rad50EP1 allele were followed during backcrossing by the presence of the w+ 
transgene and the nbs alleles by PCR. All fly stocks were obtained from the Vienna or 
Bloomington Drosophila stock centres except for UAS-Aβ1-42 (12-linker) (Speretta et 
al., 2012), which was a kind gift of Dr. Damien Crowther (University of Cambridge) and 
UAS-0N4R Tau R406W (Wittmann et al., 2001), which was a kind gift of Dr. Mel Feany 
(Harvard University).
Quantification of fly movement 
Newly eclosed adult flies were separated into cohorts of 20 flies in vials and shifted to 
29°C to begin expression by climbing assay or movement tracking.
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7Negative geotaxis climbing assays. To test climbing, flies were removed from the 
incubator and allowed to acclimatise for 1 h to the room temperature and humidity. 
Each vial of flies was tipped into an empty vial and left for 60 s to acclimatise. Flies 
were tapped to the base and allowed to climb up for 30 s. The percentage of flies 
climbing above a line 2.5 cm above the base was recorded as the mean of three 
repeats. Groups of 5 vials were tested together. Flies were transferred to fresh food 
vials after testing and returned to the incubator. For the Htt.Q128 experiment, second 
order polynomials were fitted to the data by non-linear regression in Prism 7 and 
compared by sum-of-squares F-test. For the Aβ1-42 experiment, data were compared 
by 2-way ANOVA. Significance in both cases was set at p<0.05.
Movement tracking with DART. Flies were housed individually in 65 x 5 mm locomotor 
tubes (Trikinetics). Tubes were mounted in groups of 20 horizontally on custom 
platforms and movement recorded from above via a Logitech C920 HD camera 
mounted on a copy stand. The position of each fly was determined at 5 Hz and 
movement quantified using DART software running in MATLAB 2017a (Faville et al., 
2015). Vibrational stimulation was applied 5 times at 10 min intervals to the flies via 
motors mounted to the underside of each platform and controlled by the DART 
software. The mean speed of the population of 20 flies over the 120 s before each 
stimulation, and the maximum amplitude of the population response to stimulation 
were quantified by DART. Sigmoidal trend lines were fitted to the data by non-linear 
regression in Prism 7 and compared by sum-of-squares F-test. A full description of the 
adaptation of the DART circadian behaviour system to quantify the startle response of 
flies will be published elsewhere. 
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8Circadian analysis 
tim-Gal4 was used to express Aβ1-42 in clock neurons. Flies were maintained at 25 °C 
throughout development and into adulthood in bottles. Newly eclosed adult flies were 
sorted for genotype and transferred to individual 65 x 5 mm locomotor tubes in DAM 
activity monitors (Trikinetics) and maintained in 12 h-light/12 h-dark cycle for 3 d then 
in 12 h-dark/12 h-dark for 10 d. Circadian behaviour was analysed with both spectral 
analysis using CLEAN and cosinor as described previously (Levine et al., 2002; 
Rosato and Kyriacou, 2006). Activity in the first day of DD was discarded. Genotypes 
were compared by ANOVA with a Tukey post-hoc test. Additional flies from the same 
breeding cohorts were sorted for genotype but maintained in vials in LD to maintain 
circadian cohesion. After 10 d the brains were dissected at ZT0 (just before lights on) 
and fixed and stained essentially as described (Dissel et al., 2004) except that the 
brains were incubated in primary antibodies for 4 d and in secondary antibody 
overnight (both at 4°C). Primary antibodies used were: mouse anti-PDF C7-s (1:50; 
Developmental Studies Hybridoma Bank) and rabbit anti-Per1 (1:200; Santa Cruz, CA, 
USA). Secondary antibodies were: Alexa-488 goat anti-mouse IgG and Cy3 goat anti-
rabbit IgG (both 1:100 dilution; ThermoFisher, Leicester, UK). Brains were viewed 
using an Olympus FV1000 confocal microscope. Per+ cells were counted manually 
and their identities determined based on position. For statistical analysis, the PDF+ 
lLNv and sLNv cells were considered together and, similarly, the PDF- DN1, DN2 and 
LNd cells were pooled. At least 7 brains were used per genotype. Cell numbers were 
compared by Kruskal-Wallis with a Dunn’s post-hoc test.
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9Drugs
Mirin and KU-60019 were both purchased from Tocris, Bristol, UK. Mirin is a small 
molecule inhibitor that blocks the 3’ and 5’ exonuclease activity associated with Mre11 
and prevents ATM activation in response to double strand breaks (Dupre et al., 2008; 
Stivers, 2008; Garner et al., 2009). KU-60019 is a potent ATM kinase inhibitor and has 
been used to inhibit migration and invasion of human glioma cells in vitro (Golding et 
al., 2009). 
Rat primary hippocampal neuron culture 
Primary cultures were prepared from dissected hippocampi of E18 Sprague Dawley 
rat embryos as previously described (Russell et al., 2012). Cells were plated at a 
density of either 75,000 or 500,000 cells on poly-D-lysine (Sigma, Poole, UK; 0.1 
mg/ml in borate buffer, pH 8.5) coated glass cover slips or 6-well plates respectively. 
The plating medium was DMEM supplemented with 5% FBS, penicillin/streptomycin 
(P/S) and 0.5 mM L-glutamine (all from ThermoFisher). On the next day, the medium 
was changed to Neurobasal medium supplemented with B27, P/S and 0.5 mM L-
glutamine (ThermoFisher). Cultures were incubated at 37oC and 5% CO2 and were 
used between 18 to 21 days in vitro.
Rat primary DRGN cultures 
Primary adult rat DRGN were prepared as described previously (Ahmed et al., 2005). 
DRGN cells were cultured in Neurobasal-A (ThermoFisher) at a plating density of 500 
DRGN/well in chamber slides (Beckton-Dickinson, Watford, UK) pre-coated with 100 
μg/ml poly-D-lysine. In preliminary experiments, the optimal concentration of mirin 
(100 M) and KU-60019 (10 M) that promoted DRGN survival and neurite outgrowth 
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were determined. The positive control was pre-optimised fibroblast growth factor 
(FGF)-2 (Peprotech, London, UK; 10 ng/ml (Ahmed et al., 2005)). Cells were cultured 
for 4 days in a humidified chamber at 37 oC and 5% CO2.
Rat primary retinal cultures
Primary adult retinal cultures, containing enriched populations of retinal ganglion cells 
(RGC) were prepared as described previously (Ahmed et al., 2006b). Briefly, retinal 
cells were dissociated into single cell suspensions using a Papain dissociation kit 
(Worthington Biochemicals, New Jersey, USA). 125 x 103 retinal cells/well were 
cultured in chamber slides (Beckton-Dickinson) pre-coated with 100 μg/ml poly-D-
lysine. In preliminary experiments, the optimal concentration of mirin (100 M) and 
KU-60019 (10 M) that promoted RGC survival and neurite outgrowth were 
determined. The positive control was pre-optimised CNTF (Peprotech; 20 ng/ml 
(Douglas et al., 2009)). Cells were cultured for 4 days in a humidified chamber at 37oC 
and 5% CO2.   
Preparation of Aβ oligomers and neuronal treatment 
Preparation of Aβ peptides and treatment of neurons has been previously described 
(Marsh et al., 2017). Briefly, Aβ1-42 (Bachem) was prepared by dissolving the peptide 
in DMSO (1 mM). The reconstituted peptides were diluted in 10 mM Tris, pH7.8 at a 
working concentration of 300 μM and stored in aliquots at -80 °C. Peptides were 
diluted to working concentration in full Neurobasal medium after thawing and used 
immediately. Neurons were incubated with 0.5 μM Aβ1-42 or 0.5 μM Aβ1-42 + 100 μM 
mirin for 24 h.   
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Immunocytochemistry
Adult fly brains were dissected in PBS and fixed for 20 min in 4% formaldehyde in 
PBS. After washing, brains were blocked in 1% BSA in PBS for 1 h then incubated 
with rat anti-Elav (Developmental Studies Hybridoma Bank clone 7E8A1, 1:25) and 
mouse anti-phosphorylated pH2Av (DSHB clone UNC93-5.2.1, 1:25) for 48 h at 4°C. 
Brains were washed in PBS + 0.3% triton X-100 for 2 h at RT then incubated in cross-
adsorbed Alexa-594 anti-rat and Alexa-488 anti-mouse secondary antibodies 
(Jackson ImmunoResearch, both 1:400) for 48 h at 4°C. After washing as before, 
brains were mounted on bridge slides in Vectashield (Vector Labs).
Hippocampal cells on coverslips following treatment, were rinsed once with pre-
warmed (37 °C) PBS and fixed with 4% paraformaldehyde (PFA; TAAB, Peterborough, 
UK), 2% Sucrose in PBS. Fixed neurons were washed with TBS, permeabilised with 
0.1% Tween-20 and 5% horse serum in TBS for 45 min at room temperature and 
incubated with primary antibody overnight at 4 °C. Coverslips were mounted using the 
ProLong Gold reagent (ThermoFisher). The antibodies used were: mouse anti-H2Ax 
pSer319 (H2Ax; JBW301; 1;1000 dilution; Merck) and Alexa-568 anti-mouse IgG 
(ThermoFisher). The cells were visualized on a spin disc confocal system (CARV from 
Digital Imaging Solutions) with an EM-CCD camera (Rolera/QI Cam 3500) mounted 
on an Olympus X71 microscope, using a 100x fluoplan objective (NA 4.2). The 
microscope confocal system was supported by Image Pro 6.0 software.
DRGN and RGC were fixed in 4% paraformaldehyde, washed in 3 changes of PBS 
before being subjected to immunocytochemistry as described previously (Ahmed et 
al., 2005; Ahmed et al., 2006b). Antibodies used were: mouse anti-βIII tubulin (1:200 
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dilution; Sigma) to visualise neuronal cell soma and neurites and Alexa-488 goat anti-
mouse IgG (1:400 dilution; ThermoFisher). Slides were then viewed with an 
epifluorescent Axioplan 2 microscope, equipped with an AxioCam HRc and running 
Axiovision Software (all from Zeiss, Hertfordshire, UK). The proportion of DRGN with 
neurites and the mean neurite length were calculated using Axiovision Software by an 
investigator masked to the treatment conditions as previously described (Ahmed et 
al., 2005; Ahmed et al., 2006b). All experiments were performed in triplicate and 
repeated on 3 independent occasions.
In vivo surgical procedures 
Experiments were licensed by the UK Home Office and all experimental protocols 
were approved by the University of Birmingham’s Animal Welfare and Ethical Review 
Board. All animal surgeries were carried out in strict accordance to the guidelines of 
the UK Animals Scientific Procedures Act, 1986 and the Revised European Directive 
1010/63/EU and conformed to the guidelines and recommendation of the use of 
animals by the Federation of the European Laboratory Animal Science Associations 
(FELASA). Animals were housed in a standard facility and kept on a 12-h light–12-h 
dark cycle, with a daytime luminance of 80 lux, fed and watered ad libitum. For all in 
vivo experiments, adult female Sprague-Dawley rats weighing 170-220g (Charles 
River, Margate, UK) were used. Rats were randomly assigned to each experimental 
group with the investigators masked to the treatment conditions.
Optic nerve crush injury (ONC). Rats were injected subcutaneously with 50 µl 
Buprenorphine to provide analgesia prior to surgery and anaesthetised using 5% of 
Isoflurane in 1.8 ml/l of O2 with body temperature and heart rate monitored throughout 
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surgery. ONC was performed 2mm from the lamina cribrosa using watchmaker’s 
forceps (Ahmed et al., 2005; Berry et al., 1996). 
In pilot dose-finding experiments, mirin and KU-60019 were intravitreally 
injected at 1, 2, 2.5, 5, 7.5 and 10 µg (n = 3 rats/group, 2 independent repeats), without 
damaging the lens, immediately after ONC and every other day, or twice weekly or 
once every 7 days, in a final volume of 5µl saline for 24 days (not shown). Rats were 
then killed and retinae were dissected out, lysed in ice-cold lysis buffer, separated on 
12% SDS PAGE gels and subjected to western blot detection of H2Ax levels. We 
determined that the dosing frequency of twice weekly and 2.5 and 5 µg of mirin and 
KU-60019 optimally reduced H2Ax levels, respectively. Twice weekly intravitreal 
injections were sufficient in the eye since the vitreous may acts as a slow release gel 
due to its composition, being made of mainly water, collagen type II fibrils with 
glycosaminoglycans, hyaluronan and opticin. Optimal doses were then used for all 
experiments described in this manuscript. Rats were killed in rising concentrations of 
CO2 at 1 and 24 days after optic nerve crush injury for western blot analyses or at 24 
days after ONC for determination of RGC survival and axon regeneration, as 
described below.
For the experiments reported in this manuscript, n = 6 rats/group were used 
and assigned to: (1), Intact controls (no surgery to detect baseline parameters); (2), 
ONC+vehicle (ONC followed by intravitreal injection of vehicle solution; to detect 
surgery-induced changes); (3), ONC+mirin (ONC followed by intravitreal injection of 
2.5µg of mirin, twice weekly; to monitor effects of inhibiting Mre11); and (4), ONC+KU-
60019 (ONC followed by intravitreal injection of 5µg of KU-60019; to monitor effects 
of inhibiting ATM). FluoroGold was injected into the proximal nerve stump 2d before 
sacrifice and whole retinal flatmounts were used to assess RGC survival in vivo, as 
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described by us previously (Ahmed et al., 2011). Each experiment was repeated on 3 
independent occasions with a total n = 18 rats/group/test. 
DC crush injury. For the DC lesion model, experiments also comprised n = 6 
rats/group: (1), Sham controls (Sham; to detect surgery-induced changes; partial 
laminectomy but no DC lesion); (2), DC transected controls + intrathecal injection of 
vehicle (PBS); (3), (DC+vehicle; to detect injury-mediated changes); (4), 
DC+intrathecal injection of mirin (DC+mirin; to monitor effects of inhibiting Mre11); (5), 
and DC+intrathecal injection of KU-60019 (DC+KU-60019; to monitor effects of 
inhibiting ATM). Each experiment was repeated on 3 independent occasions with a 
total n = 18 rats/group/test.
Rats were injected subcutaneously with 50 μl Buprenorphine to provide 
analgesia prior to surgery and anaesthetised using 5% of Isoflurane in 1.8 ml/l of O2 
with body temperature and heart rate monitored throughout surgery. For optic nerve 
crush injury, a supraorbital approach was used to expose the optic nerve and crushed 
with calibrated watchmaker’s forceps 2mm from the lamina cribrosa of the eye (Berry 
et al., 1996). Animals were immediately injected intravitreally and avoiding damaging 
the lens with vehicle, mirin or KU-60019. Animals were then allowed to survive for 24 
days before assessment of RGC survival and axon regeneration. For the DC injury 
model, a partial T8 laminectomy was performed and the DC were crushed bilaterally 
using calibrated watchmaker’s forceps as described (Surey et al., 2014; Almutiri et al., 
2018). The subarachnoid space was cannulated with a polyethylene tube (PE-10; 
Beckton Dickinson) through the atlanto-occipital membrane as described by others 
(Yaksh and Rudy, 1976). The catheter tip was advanced 8 cm caudally to the L1 
vertebra and the other end of the catheter was sealed with a stainless-steel plug and 
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affixed to the upper back. Animals were injected immediately with vehicle (PBS), mirin 
or KU-60019 followed by a 10l PBS catheter flush. Injections were repeated every 
24 h and drugs and vehicle reagents were delivered over 1 min time period using a 
Hamilton microlitre syringe (Hamilton Co, USA). 
In a pilot experiment, mirin and KU-60019 were injected as described above at 
1, 2, 5, 10 and 15 g (n = 3 rats/group, 2 independent repeats) in a final volume of 
10l saline either daily, every other day or twice weekly for 28 d (not shown). Rats 
were then killed and the lesion site plus 5mm either side were harvested, lysed in ice 
cold lysis buffer, separated on 12% SDS PAGE gels and subjected to western blot 
detection of H2Ax levels (Surey et al., 2014). We determined that the amount of mirin 
and KU-60019 to optimally reduce H2Ax levels by intrathecal delivery was 5 and 10 
g, respectively with a dosing frequency of every 24hrs. Optimal doses were then used 
for all experiments described in this manuscript. Rats were killed in a rising 
concentration of CO2 at either 28 d for immunohistochemistry and western blot 
analyses or 6 weeks for electrophysiology and functional tests.
Knockdown of Mre11 using shRNA in vivo.
SMARTvector Lentiviral shRNAs to Mre11 (shMre11; cat no. V3SR11242-240192989) 
and ATM (shATM; cat no. V3SR11242-238270626) under the control of a CMV 
promoter were purchased from Dharmacon and plasmid DNA was prepared from 
glycerol stocks according to the manufacturer’s instructions. A control plasmid 
containing the CMV promoter and a non-targeting control (shControl; cat no.  
VSC11721) was also purchased from Dharmacon. Plasmid DNA containing shMre11, 
shATM and shControl were complexed with in vivo-jetPEI (referred to as PEI from 
herein; Polyplus Transfection, New York, USA) according to the manufacturer’s 
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instructions and injected into the DRG immediately after DC injury, as described by us 
previously (Jacques et al., 2012; Almutiri et al., 2018). We used in vivo-jetPEI, a non-
viral vector, to deliver the shRNAs to DRGN in vivo, since we have previously shown 
that it transduces similar proportions of DRGN as adeno-associated virus 8 and that it 
does not require intra-DRG injection 1-2 week prior to injury to ensure maximum 
transgene expression (Almutiri et al., 2018). In a preliminary experiment, we optimized 
the amount of plasmid DNA required to cause maximum suppression of H2Ax+ foci 
in DRGN as 2μg for both shMre11 and shATM (not shown). Pre-optimised plasmid 
DNA was then injected intra-DRG and animals (n = 6/group/test, 3 independent 
repeats, total n = 18 rats/group/test) were killed after 28d for immunohistochemistry to 
detect H2Ax+ or 6 weeks for electrophysiological and behavioural studies. 
Immunohistochemistry 
Tissue preparation for cryostat sectioning and immunohistochemistry were performed 
as described previously (Surey et al., 2014). Briefly, rats were intracardially perfused 
with 4% formaldehyde and optic nerves, eyes, L4/L5 DRG and segments of T8 cord 
containing the DC injury sites were dissected out and post-fixed for 2h at room 
temperature. Tissues were then cryoprotected in a sucrose gradient prior to mounting 
in optimal cutting temperature (OCT) embedding medium (ThermoFisher) and frozen 
on dry ice. Samples were then sectioned using a cryostat and immunohistochemistry 
was performed on sections from the middle of the optic nerve, DRG or spinal cord as 
described previously (Surey et al., 2014). Sections were permeabilised in PBS 
containing 0.1 % Triton X-100, blocked in PBS + 3% w/v bovine serum albumin + 
0.05% Tween-20 then stained with primary antibodies overnight at 4 °C. After washing 
in PBS, sections were incubated with secondary antibodies for 1 h at RT then washed 
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further in PBS and mounted in Vectashield containing DAPI (Vector Laboratories). 
Primary antibodies used were: mouse anti-H2Ax pSer139 (H2Ax; JBW301; 1:400 
dilution; Merck) and rabbit anti-neurofilament (NF) 200 (1:400 dilution; Sigma); mouse 
anti-GAP43 (ThermoFisher; 1:400 dilution) was used to detect regenerating axons in 
the optic nerve and spinal cord. Regenerating axons in the DC were detected using 
GAP43 immunohistochemistry (Ahmed et al., 2014; Almutiri et al., 2018; Farrukh et 
al., 2019) since Cholera toxin B labelling in our hands did not label regenerating axons 
by retrograde transport labelling in the rat (Ahmed et al., 2014), despite others 
demonstrating successful labelling (Neumann and Woolf, 1999; Neumann et al., 
2002). Secondary antibodies used were Alexa-488 goat anti-mouse IgG and 
TexasRed goat anti-rabbit IgG (both from ThermoFisher). Controls were included in 
each run where the primary antibodies were omitted and these sections were used to 
set the background threshold prior to image capture. Image capture and analysis was 
performed by an investigator masked to the treatment conditions.
Quantification of axon regeneration
Axon regeneration in the spinal cord was quantified according to previously published 
methods (Hata et al., 2006). Briefly, serial parasagittal sections of cords were 
reconstructed by collecting all serial 50μm-thick sections (∼70–80 sections/animal; n 
= 10 rats/treatment) and the number of intersections of GAP43+ fibers through a 
dorsoventral orientated line was counted from 6mm rostral to 4mm caudal to the lesion 
site. Axon number was calculated as a % of fibers seen 4mm above the lesion, where 
the DC was intact. 
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Electrophysiology 
Six weeks after surgery or treatment, compound action potentials (CAP) were 
recorded after vehicle, mirin and KU-60019 treatment as previously described (Lo et 
al., 2003; Hains et al., 2004; Almutiri et al., 2018). Briefly, with the experimenter 
masked to the treatment conditions, silver wire electrodes were used apply single-
current pulses (0.05ms) through a stimulus isolation unit in increments (0.2, 0.3, 0.6, 
0.8, and 1.2 mA) at lumbar (L)1-L2 and compound action potentials (CAP) recorded 
at cervical (C)4-C5 along the surface of the midline spinal cord. CAP amplitudes were 
calculated between the negative deflection after the stimulus artefact and the next 
peak of the wave. CAP area was calculated by rectifying the negative component (full-
wave rectification in Spike 2 software) and measuring its area at the different 
stimulation intensities. The dorsal half of the spinal cord was transected between 
stimulating and recording electrodes at the end of the experiment to confirm that a 
CAP could not be detected. Electrophysiology was analysed using Spike2 software 
(Cambridge Electronic Design, Cambridge, UK) and representative processed data 
are shown for CAP traces. 
Functional tests after DC injury 
Functional testing after DC lesions was carried out as described by previously (Fagoe 
et al., 2016; Almutiri et al., 2018). Briefly, animals (n = 6 rats/group, 3 independent 
repeats (total n = 18/group/test)) randomly assigned and treatment status masked 
from the investigators, received training to master traversing the horizontal ladder for 
1 week before functional testing. Baseline parameters for all functional tests were 
established 2-3 d before injury. Animals were then tested 2 d after DC lesion + 
treatment and then weekly for 6 weeks. Experiments were performed by 2 observers 
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blinded to treatment with animals tested in the same order and at the same time of 
day. Three individual trials were performed each time for each animal.
Horizontal ladder crossing test. This tests the animals’ locomotor function and is 
performed on a 0.9-meter-long horizontal ladder with a diameter of 15.5 cm and 
randomly adjusted rungs with variable gaps of 3.5-5.0 cm. Animals were assessed 
traversing the ladder with the total number of steps taken to cross the ladder and the 
number of left and right rear paw slips being recorded. The mean error rate was then 
calculated by dividing the number of slips by the total number of steps taken.
Tape removal test (sensory function). The tape removal test determines touch 
perception from the left hind paw. Animals were held with both hind-paws extended 
and the time it took for the animal to detect and remove a 15x15mm piece of tape (Kip 
Hochkrepp, Bocholt, Germany) was recorded and used to calculate the mean sensing 
time.
Analysis of functional tests 
The whole time-course of lesioned and sham-treated animals for the horizontal ladder 
crossing and mean tape sensing/removal test was compared using generalized linear 
mixed models (GLMM) or linear mixed models (LMM), as described previously (Fagoe 
et al., 2016; Almutiri et al., 2018). For the horizontal ladder test, we scored individual 
steps as either a successful step or a slip and therefore the data follows a binomial 
distribution. Data was compared using binomial GLMM, with lesioned/sham ('LESION'; 
set to true in lesioned animals post-surgery, false otherwise) and operated/unoperated 
('OPERATED'; set to false before surgery, true after surgery) as fixed factors, animals 
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as a random factors and time as a continuous covariate. Binomial GLMMs were then 
fitted in R using package lme4 with the glmer function using the following model 
formulae (Fagoe et al., 2016):
outcome ~ LESION * time + OPERATED + (time\animal) (Model 1)
outcome ~ LESION + time + OPERATED + (time\animal) (Model 2)
outcome ~ LESION + time + OPERATED + (1\animal) (Model 3)
outcome ~ time + OPERATED + (1\animal) (Model 4)
Bracketed terms refer to the 'random effects' and account for the presence of repeated 
measurements in estimation of the effect size and significance of INT and LESION. 
'Outcome' for binomial GLMMs is a two-column list of counts of successes/fails per 
run as described in the individual models above. INT refers to the interaction term of 
LESION over time (Model 1). P-values for INT were then calculated, which represents 
differences in the evolution of outcomes over time, and LESION, the unconditional 
main effect of lesioning. Significance of specific parameters in LMMs and GLMMs can 
be determined by comparing a model containing the parameter of interest to a reduced 
model without it. Thus, INT was assessed by comparing Model 1 and Model 2, while 
LESION was assessed by comparing Model 3 and Model 4. LESION, represents the 
overall effect of lesioning on the outcome, while INT represents the difference in slope 
of the outcome between the two groups, i.e. speed of recovery. P-values for GLMMs 
were calculated by model comparison using parametric bootstrap for INT and LESION 
against the null hypothesis that each parameter is zero, using pbkrtest in R package. 
Between 1000 and 20000 simulations were used.
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For tape removal test, the time-courses of lesioned versus sham were 
compared using linear mixed models (LMMs) with the R package lme4 with the glmer 
function (Fagoe et al., 2016; Almutiri et al., 2018). Model formulae were the same as 
for the ladder crossing test above. Standard regression diagnostics (quantile plots of 
the residuals vs the normal distribution, plots of residuals vs fitted values) were carried 
out for the data fitted with LMMs. P-values for the INT and LESION parameters of the 
LMMs were calculated by model comparison using package pbkrtest in R, with the 
Kenward-Roger method. For the tape sensing and removal test, log of the withdrawal 
time was used as the data were expected to follow an exponential distribution. 
Independent sample T-tests were performed to determine statistical differences at 
individual time points.
Analysis of pH2A positive foci
Drosophila brains: Adult fly brains were dissected in PBS and fixed and stained as 
described above. 41 x 41 x 13.5m volumes of the same region of the central brain 
were imaged at 16-bit depth for each brain using a 63x water immersion N.A. 1.2 
objective on a Zeiss LSM880 confocal microscope. The zoom was set at 3.2 and z-
step at 0.45 m and Airy scan processing module used with super-resolution settings 
to improve spatial resolution post-collection. To display visualise brightly-staining 
pH2Av+ foci only, the lower intensity pan-nuclear staining was eliminated by manually 
resetting the black level threshold in Fiji-3. The identical original and processed images 
are displayed together in supplementary figures. Videos were rendered in Fiji-3.
DRGN: 1. Frequency distribution: Images of the entire DRG in the middle 3 sections 
(n = 160 images/DRG) of L4/L5 DRG from each animal (n = 10) were captured by an 
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investigator masked to the treatment conditions at x10 magnification using a Zeiss 
Axioplan 200 epifluorescent microscope. Images were merged in Adobe Photoshop 
using Photomerge and the frequency of H2Ax+ foci in different diameter DRGNs was 
recorded (Jacques et al., 2012).
2. Relative fluorescent staining intensity: the integrated density of fluorescence 
was measured using ImageJ as previously described (Surey et al., 2014). Briefly, 
images from the middle 3 DRG sections from n = 10 rats were thresholded and the 
mean integrated density of pixels/cell was recorded.
3. Western blot: Total protein was extracted from pooled L4/L5 DRG pairs from 
n = 3 rats/group (i.e. 6 DRG) after DC+vehicle, mirin and KU-60019 treatment and 
western blots followed by subsequent densitometry was performed as described by 
us previously and in brief below (Ahmed et al., 2005). Experiments were repeated on 
3 independent occasions (total n = 9 rats/group i.e. 18 DRG/group).   
Western blots 
Proteins were extracted from hippocampal, retinal or DRG neuron cultures/tissues as 
described by us previously (Ahmed et al., 2005). Briefly, cultures were treated with 
ice-cold lysis buffer (20mM HEPES pH 7.5, 1 mM EDTA, 150 mM NaCl, 1% NP-40 
and 1 mM dithiothreitol supplemented with protease (Roche, Welwyn Garden City, 
UK) and phosphatase (ThermoFisher) inhibitor cocktails), protein concentration was 
determined by Bradford Protein Assay and 15 μg of total protein separated on 12% 
Tris-glycine SDS-PAGE gels. Proteins were transferred to nitrocellulose membranes, 
blocked with 2.5% non-fat dry milk in TBS containing 0.05% Tween-20 for 90 min with 
agitation then incubated for 2 h with primary antibodies and for 1 h with secondary 
antibodies diluted in 2.5% non-fat dry milk at RT. For hippocampal neurons, proteins 
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were detected using the Odyssey imaging scanner (LI-COR). Primary antibodies used 
were: mouse anti-Synapsin antibody (Santa Cruz) and mouse anti-actin antibody 
(Sigma, A5316). Secondary antibodies used were: Alexa-680 goat anti-mouse IgG 
and Alexa-800 goat anti-rabbit IgG (New England Biolabs). For DRGN cultures, 
membranes were probed with primary anti-H2Ax (pSer139 monoclonal antibody; 
1:400 dilution; Merck) and HRP-labelled anti-mouse secondary antibody before bands 
being detected using an enhanced chemiluminescence kit (GE Healthcare, 
Buckingham, UK). β-actin (Sigma: 1:1000 dilution) was used as a protein loading 
control for western blots.     
Densitometry 
Western blots were scanned into Adobe Photoshop (Adobe Systems, San Jose, CA, 
USA) keeping all scanning parameters constant between blots. The integrated density 
of bands was analysed using the built-in macros for gel analysis in ImageJ as 
described by us previously (Ahmed et al., 2006a).
Statistical analysis
All data are presented as means ± standard error of the mean (SEM). Comparison of 
means were performed using one-way or two-way ANOVA using Prism 7 (San Diego, 
CA, USA) or SPSS (Version 25, IBM, New York, USA). Tukey’s significant difference 
test followed ANOVA’s, as appropriate. In Fig. 2A a Kruskal-Wallis test with Dunn’s 
post-hoc was performed. Functional tests in rats were analysed using R package 
(www.r-project.org) as described above. Tests used for each experiment are 
described in the corresponding methods. In all tests, P<0.05 were considered 
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statistically significant. Supplementary Table 1 lists all tests performed, the 
comparisons made, and the associated P-values. 
Data availability 
The authors confirm that the data supporting the findings of this study are available 
within the article and its Supplementary material.  
Results 
Genetic targeting of the double strand break-sensing MRN complex is neuroprotective 
in Drosophila. Double strand breaks are a feature of early-stage Alzheimer’s disease 
and correlate with reduced cognitive score (Simpson et al., 2015). Double strand 
breaks are also generated in neurons in vivo exposed to Aβ1-42 oligomers (Suberbielle 
et al., 2013). Hence, we chose to target the MRN complex in a Drosophila model of 
Alzheimer’s model as proof-of-concept. In this model, tandem Aβ1-42 oligomers for 
Alzheimer’s disease (AD) were expressed in, and secreted from, adult post-mitotic 
neurons to replicate the extracellular deposition in AD (Speretta et al., 2012). 
Expression was restricted to adult neurons only to rule out confounding developmental 
phenotypes (see Methods for genetics). First, we confirmed that double strand breaks 
were generated in neurons exposed to Aβ1-42 oligomers, as predicted from other 
studies and our own studies in rat hippocampal neurons (Fig. 2). Activation and 
recruitment of ATM to the site of double strand breaks lead to multiple phosphorylation 
events, one of which is the phosphorylation of histone H2Ax at and around the site of 
the break, resulting in the formation of characteristic H2Ax+ nuclear foci (Shrivastav 
et al., 2008). Therefore, antibodies to H2Ax (H2Av in Drosophila) are widely use to 
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visualise the histone modifications surrounding a double strand break (Celeste et al., 
2002; Simpson et al., 2015; Milanese et al., 2018). Anti-pH2Av staining of control 
brains revealed neurons with a single brightly staining focus per nucleus 
corresponding to the nucleolus organizing centre. In contrast, many of the Aβ1-42-
expressing neurons had multiple, clustered foci (Fig. 1A, Supplementary Fig. 1 and 
Video 1).
Next, we asked whether reducing nbs levels genetically would be 
neuroprotective in A1-42 expressing flies. We chose to introduce one null allele of nbs 
to reduce the gene dosage by 50% and then used the ability of flies to climb after being 
startled as a measure of neural output. This negative geotaxis assay is widely used in 
Drosophila neurodegeneration studies: climbing ability declines rapidly and correlates 
with a reduced speed of neural transmission (Kerr et al., 2011). In flies expressing A1-
42 oligomers, climbing ability decreased rapidly with age yet this was partially 
suppressed in nbs-/+ heterozygous flies (Fig. 1B and see Video 2). The toxicity of the 
less aggregative tA1-42 construct lacking the 12 amino acid flexible linker was similar 
suppressed in nbs1/+ heterozygous flies and a second null allele, nbs2/+ showed a 
similar effect (Supplementary Fig. 2A and B).
To confirm that the neuroprotective effect was not specific to Aβ1-42 pathology, 
we used the same approach for flies expressing an expanded Htt protein associated 
with Huntington’s disease (Htt.Q128) (Romero et al., 2008) and saw a similar 
neuroprotective effect in climbing assays (Fig. 1C). Again, to confirm the suppression 
was not specific to climbing ability, we switched to a tracking system capable of 
monitoring the horizontal movement of flies continuously and expressed the human 
0N4R Tau carrying the R406W point mutation associated with frontal temporal 
dementia with Parkinsonism (Wittmann et al., 2001). Tau-expressing flies moved at 
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normal speed when unstimulated (not shown) but their escape response declined 
rapidly with age. Again, this was partially suppressed in nbs-/+ flies (Fig. 1D) and this 
neuroprotective effect was not due to a reduction in Tau levels nor to changes in Tau 
phosphorylation in the brains of these flies (Supplementary Fig. 2C). Finally, to ensure 
these protective effects were not specific to nbs, we depleted rad50 in Htt.Q128-
expressing flies using the same strategy of reducing the gene dosage with a null allele. 
Flies with reduced rad50 (rad50-/+) partially suppressed the decline in climbing ability 
in the Htt.Q128 flies (Supplementary Fig. 2D). We also expressed expanded HttQ128 
in the developing eye under the control of GMR-gal4, which generates a progressive 
degeneration evidenced as a widespread loss of pigmentation after 6-7 weeks 
(Romero et al., 2008). In rad50-/+ flies, pigmentation is restored, indicating enhanced 
cellular survival (Supplementary Fig. 2E).
Targeting the MRN complex suppresses neurodegeneration-relevant 
phenotypes 
AD patients commonly suffer disrupted circadian behaviour patterns (Saeed and 
Abbott, 2017) and a similar effect is observed in Aβ-expressing flies (Long et al., 2014). 
We asked whether reducing nbs genetically would suppress this more directly 
disease-relevant phenotype. Tandem Aβ1-42 was expressed specifically in clock 
neurons under the control of tim-Gal4 and their survival studied with 
immunocytochemistry (Renn et al., 1999). Aβ-expression induced loss of some Per+ 
neurons but this was partially suppressed in nbs-/+ flies (Fig. 2A). Consistent with the 
loss of clock neurons (Renn et al., 1999), Aβ-expressing flies exhibited significantly 
longer free-running circadian locomotor cycles than controls but the normal ~24 h 
periodicity was restored in nbs-/+ flies (Fig. 2B and Supplementary Fig. 2F). 
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We extended our findings to mammalian neurons by examining synapse loss – 
a common early feature of neurodegenerative diseases (Gillingwater and Wishart, 
2013). Cultured primary hippocampal neurons were exposed to Aβ1-42 oligomers and 
stained with anti-H2Ax antibodies. As expected, the characteristic foci corresponding 
to double strand breaks in the nuclei were induced by exposure to Aβ1-42 (Fig. 2C). 
Synapsin levels were significantly reduced 24 h after addition of Aβ oligomers (Fig. 
2D) suggesting that one route to synapse loss in AD might be via Aβ-induced double 
strand breaks triggering the DNA damage response. Mirin, a small-molecule Mre11 
exonuclease inhibitor (Dupre et al., 2008), prevented synapsin loss (Fig. 2D), 
indicating that targeting the MRN complex can also protect mammalian neurons from 
changes associated with early-stage neurodegeneration.
Mre11 or ATM inhibition prevents apoptosis and stimulates regeneration after 
neurotrauma
Double strand breaks are a feature of acute neurological disorders (Hayashi et al., 
1998; Kotipatruni et al., 2011). DNA strand breaks have been observed in retinal 
ganglion cells (RGC) after optic nerve injury (He et al., 2012) and neurons suffering 
from ischemia display genome fragility and fragmented DNA both in vitro and in vivo 
(Yang et al., 2016). We used an adult rat primary retinal culture system enriched in 
RGC, where cells are grown in the presence of inhibitory CNS myelin extracts to 
simulate a post-injury environment (Ahmed et al., 2006b). As expected, we detected 
the presence of double strand breaks with anti-H2Ax antibodies in the RGC (Fig. 3A 
and B). The RGC die rapidly by apoptosis and, even if apoptosis is blocked with 
inhibitors, they fail to regenerate neurites (Vigneswara et al., 2013). We treated the 
RGC with mirin to attenuate the DNA damage response. This blocked RGC apoptosis 
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and dramatically stimulated neurite regrowth. Mirin treatment was significantly more 
effective than a current positive control treatment: ciliary neurotrophic factor (CNTF) 
(Fig. 3C and D). Since a key function of the MRN complex is to recruit and activate 
ATM at double strand breaks (Lee and Paull, 2005), and given that HD-pathology is 
reduced by targeting ATM (Lu et al., 2014), we asked whether inhibiting ATM directly 
would also be neuroprotective to RGC. Treatment with the highly selective ATM 
inhibitor, KU-60019, had similarly dramatic effects on RGC survival and neurite 
outgrowth as mirin (Fig. 3C-F). 
We extended our in vitro findings to an in vivo optic nerve crush injury paradigm. 
We observed low levels of H2Ax in intact control rat retinae in vivo (Fig. 4A and B). 
However, high levels of H2Ax were observed within 1 d and at 24 d after optic nerve 
crush injury, suggesting rapid activation of double strand breaks and persistence of 
high levels for the duration of the experiment i.e. 24 days. Thus, the DNA damage 
response pathway was persistently activated in the retina post-injury. We used a pre-
optimized dosing regimen for mirin and KU-60019 for 24 days after optic nerve crush 
injury to attenuate the DNA damage response, as demonstrated by significantly 
suppressed H2Ax in western blots (Fig. 4C) and subsequent densitometry (Fig. 4D) 
and saw unprecedented RGC survival of 93% and 91%, respectively, when compared 
to intact controls (Fig. 4E and F). Both mirin and KU-60019 also promoted significant 
numbers of RGC to regenerate their axons, which emerged from the lesion site and 
grew for long distances (Fig. 4G and H). The numbers of regenerating axons we see 
are, to the best of our knowledge, unprecedented when compared to known 
treatments and the axons also regenerate longer distances into the distal optic nerve 
than has been seen previously (Berry et al., 1996; Leon et al., 2000; Vigneswara et 
al., 2013).
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Mre11 and ATM inhibitors promote DRGN survival and neurite outgrowth in vitro 
and DC axon regeneration after spinal cord injury in vivo
Double strand breaks are also generated in spinal neurons after spinal cord injury 
(SCI) (Kotipatruni et al., 2011) and there is an urgent need for effective therapies to 
treat SCI patients. Initially, we tested our DNA damage response attenuation strategy 
using a similar in vitro culture model to the retina in which dorsal root ganglion neurons 
(DRGN) containing double strand breaks are cultured from adult rats and grown in the 
presence of inhibitory CME (Supplementary Fig. 3A). Again, mirin and KU-60019 
treatment stimulated significant DRGN survival and promoted neurite outgrowth 
(Supplementary Fig. 3B-E).
To generate a spinal cord injury in vivo, we surgically injured the ascending long 
tract axons of the dorsal funiculus in adult rats by dorsal column (DC) crush injury 
(Surey et al., 2014) and mirin or KU-60019 inhibitors were administered through an 
intrathecal catheter. None of the animals showed adverse effects to SCI and all 
animals were included for analysis. Double strand breaks formed in DRGN of all 
diameters after DC+vehicle treatment, as predicted from previous studies (Kotipatruni 
et al., 2011) (Fig. 5A and B). However, quantification of the intensity of H2Ax+ was 
significantly reduced in DC+mirin and DC+KU-60019-treated animals (Fig. 5C). 
Similarly, western blot and subsequent quantification for H2Ax levels showed 
significant attenuation in DC+mirin and DC+KU-60019-treated rats, indicating partial 
suppression of the DNA damage response (Fig. 5D and E).
We next investigated if suppression of DNA damage response by mirin and KU-
60019 promotes DC axon regeneration after injury in rats. Little or no GAP43+ 
D
ow
nloaded from
 https://academ
ic.oup.com
/braincom
m
s/advance-article-abstract/doi/10.1093/braincom
m
s/fcz005/5526876 by Aston U
niversity user on 08 July 2019
30
immunoreactivity was detected in DC+vehicle-treated rats whilst a large cavity was 
present at the lesion site (#) (Fig. 6A). Quantification of the % of axons in DC+vehicle-
treated rats falls rapidly to 0% at the lesion site (i.e. 0mm) and remains at 0% for all 
distances quantified (Fig. 6B). In DC+mirin and DC+KU-60019-treated rats, significant 
GAP43+ immunoreactivity was present beyond the lesion cavity and in the rostral 
segment of the spinal cord (Fig. 6A and B). Quantification of the % of axons 
demonstrated significantly enhanced numbers at all distances when compared to 
DC+vehicle-treated rats, with DC+KU-60019 treatment regenerating slightly greater 
numbers of GAP43+ axons at all distances rostral to the lesion (Fig. 6B). For example, 
DC+KU-60019 treatment regenerated 47 ± 8, 35 ± 6, 25 ± 4 and 18 ± 3% of axons at 
0, 2, 4 and 6mm rostral to the lesion site, compared to DC+vehicle-treated rats (Fig. 
6B). 
Mre11 and ATM inhibitors restore function after spinal cord injury in vivo
We employed electrophysiology and simple functional tests (Almutiri et al., 2018) to 
quantify recovery from the injury after mirin or KU-60019 treatment. In DC+vehicle-
treated rats, the normal compound action potential (CAP) trace across the lesion site 
in Sham controls was abolished, whilst treatment with either mirin and KU-60019 
restored 50-55% of the CAP trace (Fig. 7A) and the CAP amplitude (Fig. 7B) observed 
in sham-treated animals. As expected, dorsal hemisection between the stimulating 
and the recording electrodes at the end of the experiment abolished CAP traces in all 
animals (if a CAP trace was observed), confirming that the experiment was technically 
successful (Fig. 7A). The CAP area was also significantly improved in mirin and 
KU60019-treated rats compared to vehicle groups (Fig. 7C). The improved 
electrophysiological function translated into very dramatic improvements in sensory 
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and locomotor function. We used a tape sensing-and-removal test and a horizontal 
ladder-crossing test to quantify recovery of sensory and motor function, respectively 
(Almutiri et al., 2018). In sham-treated animals, there is a small initial decline in mean 
sensing/removal time (Fig. 7D) and mean ratio of slips to total steps (Fig. 7E) due to 
the effects of anaesthetic but these are restored to baseline levels within 3 weeks. 
Vehicle-treated groups displayed significantly impaired sensory and motor function 
that failed to return to baseline levels even after 6 weeks. In contrast, mirin or KU-
60019-treated groups both showed dramatically improved sensing times and ladder-
crossing ability 2d after surgery and after 3 weeks were indistinguishable from the 
sham-treated control. These results demonstrate that either Mre11 or ATM inhibition 
is able to promote functional recovery after SCI in vivo, which we believe to be at 
unprecedented levels.
Finally, we confirmed the results obtained with the inhibitors using specifically 
designed shRNA plasmids targeting Mre11 (shMre11) and ATM (shATM). These 
shRNA plasmids were delivered using a non-viral gene delivery vector, in vivo-JetPEI 
(PEI), which we have shown to be as efficient as AAV8 in transducing DRGN after 
Intra-DRG injection in vivo and does not invoke an off-target immune response 
(Almutiri et al., 2018). We initially demonstrated significant knockdown of Mre11 and 
ATM mRNA (84% compared to DC+PEI-shControl) in vivo using in vivo-JetPEI 
(Supplementary Fig. 4A). The intensity and the number of H2Ax+ pixels/cell as a 
measure of double strand breaks, were also significantly attenuated after DC+PEI-
shMre11 and DC+PEI-shATM treatment indicating that knockdown of Mre11 and ATM 
reduces double strand breaks (Supplementary Fig. 4B and C). Electrophysiology 
across the lesion site after treatment with shMre11 and shATM demonstrated similar 
improvements in CAP amplitude (Supplementary Fig. 4D) and CAP area 
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(Supplementary Fig. 4E) as observed after treatment with mirin and KU-60019. The 
mean sensing and removal time (Supplementary Fig. 4F) and mean ratio of slips to 
total steps (Supplementary Fig. 4G) in the sensory and locomotor tests were also 
similarly improved, with animals also being indistinguishable from sham-treated 
animals by 3 weeks, when compared to mirin and KU-60019 treatment. These results 
demonstrate that knockdown of Mre11 and ATM as well as mirin and KU-60019 
treatment to inhibit the DNA damage response is functionally beneficial after spinal 
cord injury.    
Discussion 
Double strand breaks occur in both long-term and acute forms of neurological disease, 
including Alzheimer’s, Parkinson’s and Huntington’s diseases, amyotrophic lateral 
sclerosis, post-cerebral ischaemia and following spinal cord injury: potentially they are 
a universal feature. If double strand breaks accumulate in neurological conditions, 
attenuating the DNA damage response as a therapeutic strategy logically should 
enhance disease rather than suppress it. Here, we demonstrate the opposite is true: 
inhibiting apical components of the DNA damage response to mute the response to 
double strand breaks is beneficial in models of neurodegeneration and results in 
unprecedented survival, axon regeneration and recovery of function after 
neurotrauma. 
Attenuating the DNA damage response in neurodegenerative disease
The incidence of double strand breaks in the brains of AD patients has only recently 
been quantified. Double strand breaks accumulate in early-stage AD and correlate 
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with reduced cognitive scores (Simpson et al., 2015). It is plausible that these un-
repaired double strand breaks trigger the cell-cycle re-entry phenomena in AD brains 
described in the 1990s (McShea et al., 1997; Nagy et al., 1997) and the increase in 
senescence identified more recently (He et al., 2013; Wei et al., 2016). Consistent with 
cell cycle re-entry affecting neural health and acting as trigger for apoptosis, inhibitors 
of cell cycle progression have shown some efficacy in cerebral ischemia models 
(Osuga et al., 2000) and have been suggested as therapies in neurodegeneration 
(reviewed in (Kruman and Schwartz, 2008)). Similarly caffeine, a non-specific inhibitor 
of ATM, is neuroprotective against etoposide-induced DNA damage to neurons in vitro 
(Kruman et al., 2004) and reducing ATM gene dosage is neuroprotective in a mouse 
model of HD (Lu et al., 2014). However, ATM inhibitors have not yet been tested in 
trials for neurodegeneration. In addition to double strand breaks, ATM is activated by 
multiple inputs, including reactive oxygen species, has a reported 700 potential 
downstream phosphorylation targets in multiple pathways. In contrast, the MRN 
complex has no reported functions other than in DNA damage repair, which potentially 
makes it a simpler target for therapy.
Would long-term targeting of the MRN complex as a therapeutic strategy for 
neurodegeneration cause cancer?  Potentially, yes. However, heterozygous carriers 
of mutations in Mre11, Rad50, Nbs1/Nbn have only a small increase in cancer 
incidence over the lifecourse (Bartkova et al., 2008; Kuusisto et al., 2011; Damiola et 
al., 2014). This suggests that targeting the MRN complex may a feasible strategy, 
particular for more rapidly progressing neurodegenerative disorders such as ALS. 
Potentially, a genetic approach to partially knockdown MRN complex levels via shRNA 
would be more effective and could be largely restricted to the CNS using viral delivery.
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Attenuating the DNA damage response in optic nerve injury
Clinically, the optic nerve crush injury model is directly relevant to glaucoma and other 
eye diseases where RGC death occurs such as ischemic optic neuropathy. For 
example, we previously evaluated the effect of an siRNA to caspase-2 (siCASP2) in 
protecting RGC from death in the same model used in this paper (Ahmed et al., 2011; 
Vigneswara et al., 2014). The siCASP2 is currently in Phase III clinical trials for the 
treatment of non-arteritic ischemic optic neuropathy as a result of our preclinical work 
(Ahmed et al., 2011); http://www.eyeactnow.com). Attenuation of the DNA damage 
response after optic nerve crush injury in vivo using Mre11 or ATM inhibitors 
significantly neuroprotected RGC from death. RGC neuroprotection was >90% after 
inhibition of mirin and KU-60019, which is on a par with the inhibition of caspase-2 
using an siRNA (siCASP2) (Ahmed et al., 2011; Vigneswara and Ahmed, 2016). Out 
of all of the strategies to promote RGC neuroprotection, siCASP2 treatment appears 
to be the most effective (Thomas et al., 2017). Other treatments such as lens injury 
and cAMP+oncomudulin only protect to a maximum of 24% of RGC at 21 days after 
ONC (Leon et al., 2000; Yin et al., 2006). Even combinatorial treatments such as PTEN 
deletion + zymosan + cAMP only protected a maximum of 36% of RGC at 10-12 weeks 
after ONC (de Lima et al., 2012). The delivery of CNTF, a well-studied neurotrophic 
factor for RGC, promoted <60% RGC survival at 2 weeks (Pernet et al., 2013), 
declining to 31% at 5 weeks (Leaver et al., 2006) and 20% at 8 weeks (Pernet et al., 
2013) after ONC. In contrast, twice weekly injections of mirin and KU-60019 
neuroprotected >90% of RGC at 24 days after ONC. Although we have not studied 
time-points beyond 24 days, we would expect that this level of neuroprotection would 
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continue as we have observed for siCASP2 for 12 weeks after ONC (Vigneswara and 
Ahmed, 2016). Therefore, inhibition of Mre11 and ATM to our knowledge is on par with 
the current best treatment for RGC neuroprotection, namely siCASP2.        
Importantly, although siCASP2 offers >90% RGC neuroprotection, it does not 
promote RGC axon regeneration (Vigneswara et al., 2014). In contrast, Mre11 and 
ATM inhibitors not only promoted significant RGC survival, but also promoted 
significant RGC axon regeneration. Other treatments such lens injury and 
cAMP+oncomodulin only promote the regeneration of <1000 RGC axons at 1mm from 
the lesion at 21 days after ONC (Leon et al., 2000; Yin et al., 2006). Zymosan+cAMP 
and PTEN deletion+Zymosan+cAMP only promote the regeneration of <100 axons at 
3mm from the lesion site at 2 weeks after ONC (Kurimoto et al., 2010; de Lima et al., 
2012). Meanwhile, CNTF only promotes the regeneration of <20 axons at 1.5mm 
beyond the lesion site after 2 weeks and <50 axons at 4mm beyond the lesion site 
after 8 weeks (Leaver et al., 2006; Pernet et al., 2013). Our results showing robust 
RGC axon regeneration of >1000 axons at 4mm beyond the lesion site suggest that 
inhibition of Mre11 and ATM supersedes some of the best treatments that have been 
reported to date to promote RGC axon regeneration. Moreover, our results 
demonstrate that mirin or KU-60019 on their own cannot only protect RGC from death 
but also promote their axons to regenerate, making translation to the clinical scenario 
easier due to the requirement of delivering a single molecule to activate both 
neuroprotective and axon regenerative pathways.  
  
Attenuating the DNA damage response in SCI
Attenuation of the DNA damage response after DC injury using Mre11 or ATM 
inhibitors promoted significant DC axon regeneration and electrophysiological, 
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sensory and locomotor improvements. This is despite the presence of spinal cord 
cavities that are characteristic of DC crush injury in the rat. However, after DC injury, 
DRGN do not die and hence neuroprotection in vivo could not be assessed. 
Nonetheless, in vitro experiments with both Mre11 and ATM inhibitors demonstrated 
significant DRGN neuroprotection and hence we can surmise that the inhibitors are 
DRGN neuroprotective. The recovery of function after SCI in adult rats administered 
Mre11 or ATM inhibitors and confirmed using shMre11 and shATM, is striking and, to 
the best of our knowledge, unprecedented. The improvements in sensory and 
locomotor function that we achieved are perhaps more remarkable given that DC injury 
in adult rats results in spinal cord cavities but cavitation is absent after DC injury in the 
mouse (Surey et al., 2014). Instead in the mouse, the lesion sites fill with dense fibrous 
connective tissues which allow some regeneration of axons (Bilgen et al., 2007). In 
contrast, cavitation in the rat results in worsening of the initial injury, leading to 
disconnection of more axons over a period of several months (Tang et al., 2003; 
Byrnes et al., 2010).
Blunt injury, such as compression or contusion, account for more than >80% of 
all SCI in humans (Taoka and Okajima, 1998; Metz et al., 2000; Brechtel et al., 2006). 
Our rat DC crush model replicates many aspects of the human pathology well, 
including evolution of the injury over time and morphological aspects, such as spinal 
cord atrophy, myelomalacia, cavity, cyst and syrinx formation and cord disruption 
(Gruner, 1992; Taoka and Okajima, 1998; Kwon et al., 2002). Importantly, cavity and 
cysts form and increase over time, thus transecting more axons and causing ongoing 
damage to the spinal cord architecture. Our study, therefore, addresses axon 
regeneration and functional recovery in a model that cavitates, as opposed to mouse 
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models where cavitation is absent. Taken together, these clinically relevant features 
suggest our approach could be a very effective therapy for patients. 
The Mre11 and ATM inhibitors used in this study are potent, small molecule 
inhibitors that are specific for their targets and have a low IC50. These inhibitors were 
developed has chemotherapy agents for cancer. DNA damage-induced tumour cell 
killing has been demonstrated in preclinical models with mirin and KU-60019 (Hosoya 
and Miyagawa, 2014) and other ATM inhibitors are currently in trials that potentially 
could be re-purposed for SCI. Importantly, our method of administering the 
compounds – by intrathecal injection – can be translated directly to human therapy, 
This method gives direct access of compounds to the injury site, which often requires 
lower drug doses with greater efficiency than other routes of administration (Bottros 
and Christo, 2014), limiting the potential unwanted side effects on other cells in the 
CNS such as glia. 
In our experiments, the mirin and KU-60019 compounds were delivered directly 
after injury but this could also happen in human patients since most cases attend 
emergency care immediately. For neurodegeneration, a viral-mediated genetic 
knockdown approach may prove to be more effective by effecting a partial knockdown 
in MRN complex levels over a longer period; this may also prove to be the case in SCI 
treatments. However, there are caveats to this approach. Inhibiting the DNA damage 
response may have negative consequences to cells and system functions if applied 
systemically. Even if used intrathecally as suggested by us, there may be negative 
consequences on dividing cells such as glia in the CNS. Hence, caution must be used 
when using these compounds in treating human conditions.  
Current therapies for SCI are limited and only offer palliative relief with none 
reversing the underlying damage to axons. Methylprednisolone is the only 
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pharmacotherapy that is currently approved for use in SCI, but this has failed to show 
clinically significant effects and is now often used off-label (Varma et al., 2013). 
Several other experimental therapies are currently in the early phases of development, 
including the Rho antagonist, Cethrin; anti-Nogo antibodies and autologous 
mesenchymal stem cell transplants. However, completed clinical trials of these 
reagents have either not been reported, abandoned or concluded with no significant 
improvements reported. Consequently, there is a clear unmet need for a therapy in 
SCI that would not only promote neuroprotection but also promote axon regeneration. 
It is clear from our previous work that neuroprotection and axon regeneration are 
signalled by different signalling pathways (Ahmed et al., 2010) and our study is the 
first to report single inhibitors capable of stimulating both processes. A ‘single hit’ 
molecule that can modify both neuroprotective and axon regenerative pathways would 
be an additional advantage for a potential therapy to treat the devastating loss of 
function that ensues after SCI in humans. Here, we report that DNA damage response 
inhibitors are good candidates.
In conclusion, our paper highlights a novel therapeutic strategy by targeting the 
response of neurons to double strand breaks to protect neurons from death and 
promote their axon regeneration. This strategy prevents loss of function in multiple 
neuropathological paradigms and suggests new treatment possibilities for 
neurological conditions.
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Figure legends
Figure 1. Targeting the MRN complex is neuroprotective in Drosophila models 
of neurodegeneration. (A) Expression of tAβ1-42 in adult neurons generates DNA 
double-strand breaks. Projections of central brain neurons stained with anti-pH2Av. 
Control neurons display a single pH2Av+ focus per nucleus corresponding to the 
nucleolus organising region. Multiple neurons expressing Aβ1-42 display large numbers 
of clustered foci (arrowheads). (B) Flies were startled by tapping to the base of a vial 
and the negative geotaxis climbing response quantified as a measure of neural output. 
Flies expressing (B) Aβ1-42 or (C) Htt.Q128 in adult neurons show a rapid decline in 
climbing ability which is partially suppressed in flies heterozygous for a null allele of 
nbs. Statistical comparisons in (B) by 2-way ANOVA and in (B) by extra sum-of-
squares F-test, *** indicates p<0.001. (D) When stimulated by vibration, Tau-
expressing flies show a rapid decline in the startle response which is partially 
suppressed in nbs-/+ flies. Dashed arrows indicate days of expression required for 50% 
decline in response determined from fitted lines; comparison by 2-tailed t-test. Scale 
bars in (A) = 10µm.
Figure 2. Targeting the MRN complex protects against Alzheimer’s disease-
relevant phenotypes. (A) Expression of A1-42 in clock neurons leads to loss of Per+ 
cells. In nbs-/+ flies, loss of cells is partially prevented (Kruskal-Wallis with Dunn’s post-
hoc test; p values and n are indicated). (B) The free-running circadian locomotor cycle 
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of control flies is ~24 h but is considerably lengthened when A1-42 is expressed in 
clock neurons indicating weaker rhythmicity in the circadian circuitry. The increase is 
suppressed in nbs-/+ flies (CLEAN spectral analysis; comparisons by ANOVA with 
Tukey’s post-hoc test; p values and n are indicated). (C) Exposure of rat hippocampal 
neurons to A1-42 oligomers in vitro generate double strand breaks that can be 
visualized by staining with anti-H2Ax (red). DNA is visualized with DAPI (blue). (D) 
Quantification of synapsin levels in hippocampal neurons by Western blot. Exposure 
to A1-42 oligomers leads to loss of the pre-synaptic protein, synapsin, which is 
reversed by the Mre11 inhibitor, mirin (mean ± SEM; ANOVA with Tukey’s post-hoc 
test; P values and n are indicated). Scale bars in (C) = 10µm.
Figure 3. Inhibition of Mre11 prevents RGC apoptosis and stimulates neurite 
outgrowth after 4 days in culture in the presence of inhibitory CNS myelin 
extracts. (A) Western blot and (B) subsequent densitometry to show attenuated levels 
of anti-H2Ax after treatment with mirin and KU-60019. (C) Mirin or KU-60019 
significantly enhanced RGC survival. (D) Representative images from RGC treated 
with vehicle, CNTF (positive control), mirin and KU-60019. Mirin or KU-60019 
treatment (E) increased the mean RGC neurite length and (F) % RGC with neurites. 
n = 3 wells/treatment, 3 independent repeats (total n = 9 wells/condition). AU = 
arbitrary units. Comparisons in (B), (C), (E) and (F) by one-way ANOVA with Dunnett’s 
post-hoc test. Scale bars in (D) = 100µm.
Figure 4. Inhibition of Mre11 and ATM prevents RGC apoptosis and stimulates 
axon regeneration at 24 days after optic nerve crush injury. (A) Western blot and 
(B) subsequent densitometry to show phosphorylation of H2Ax (H2Ax) as a marker 
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of DNA damage after optic nerve crush injury (n = 6 retinae/time-point, 3 independent 
repeats (total n = 18 retinae/time-point)). (C) Western blot and (D) densitometry to 
show that mirin and KU-60019 significantly suppress optic nerve crush injury-induced 
H2Ax levels (n = 6 retinae/time-point, 3 independent repeats (total n = 18 
retinae/condition). (E) Representative images and (F) quantification of FluoroGold 
backfilled RGC in retinal wholemounts to demonstrate that mirin and KU-60019 
significantly enhanced RGC survival at 24 days after optic nerve injury (n = 6 
retinae/time-point, 3 independent repeats (total n = 18 retinae/condition). (G) 
representative images and (H), quantification to show that mirin and KU-60019 
significantly enhanced RGC axon regeneration as detected by GAP43 
immunoreactivity (n = 6 nerves/condition, 3 independent repeats (total n = 18 
nerves/condition). AU = arbitrary units. Comparisons in (B), (D), (F) and (H) by one-
way ANOVA with Dunnett’s post-hoc test. Scale bars in (E) = 50µm and in (G) = 
200µm).
Figure 5. Inhibition of Mre11 and ATM reduces the number of DRGN with double 
strand breaks and the levels of H2Ax after DC injury in vivo. (A) Representative 
images from DC+vehicle, DC+mirin and DC+KU-60019-treated sections of rat DRGN 
(n = 6 rats/group, 3 independent repeats; total n = 18 rats/group) demonstrating H2Ax 
(green) localization in the nucleus of DRGN (red). Images are counterstained with 
DAPI (blue) to demarcate the nucleus. (B) Quantification of the frequency of H2Ax+ 
DRGN sorted by different soma size. (C) Quantification of the mean pixel 
intensity/DRGN in DC+vehicle, DC+mirin and DC+KU-60019-treated DRGN. (D) 
Western blot and (E) subsequent densitometry to demonstrate reduction of H2Ax 
protein levels in DRGN after treatment with mirin and ATM inhibitors.  AU = arbitrary 
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units. Comparisons in (C) and (E) by one-way ANOVA with Dunnett’s post-hoc test. n 
= 6 rats/treatment, 3 independent repeats (total n = 18 rats/treatment). Scale bars in 
A = 50µm, insets in A = 10µm.
Figure 6. Intrathecal injection of Mre11 and ATM inhibitors promote significant 
axon regeneration at 6 weeks after spinal cord injury. (A) GAP43+ (green) 
immunoreactivity was largely absent in DC+vehicle-treated groups (Blue = DAPI+ 
nuclei). However, in DC+mirin and DC+KU-60019-treated rats, enhanced GAP43+ 
immunoreactivity was present in the rostral segment of the spinal cord in beyond the 
lesion site (#) where a large cavity remained. (B) Quantification of the % of axons at 
different distances rostral to the lesion site showed significantly enhanced numbers of 
GAP43+ regenerating axons at all distances tested after treatment with DC+mirin and 
DC+KU-60019. (n = 10 nerves/condition). Scale bars in (A) = 200µm. Comparisons in 
(B) by one-way ANOVA with Dunnet’s post-hoc test (DC+vehicle vs DC+KU-60019).   
 
Figure 7. Intrathecal injection of Mre11 and ATM inhibitors promotes significant 
functional repair after spinal cord injury. (A) Spike 2 software processed CAP 
traces from representative sham controls, DC+vehicle, DC+mirin and DC+KU-60019-
treated rats showing some recovery of dorsum cord potentials in mirin and KU-60019-
treated rats. Dorsal hemisection between the stimulating and the recording electrodes 
at the end of the experiment ablated CAP traces in all animals demonstrating technical 
success of the experiment. (B) Negative CAP amplitudes were significantly attenuated 
in DC+vehicle-treated rats but were significantly improved in DC+mirin and DC+KU-
60019-treated rats (P<0.0001, one-way ANOVA (main effect)). (C) Mean CAP area at 
different stimulation intensities were significantly attenuated in DC+vehicle-treated rats 
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but improved significantly in DC+mirin and DC+KU-60019-treated rats (P<0.0001, 
one-way ANOVA (main effect)). (D) Mean tape sensing and removal time are restored 
to normal 3 weeks after treatment with mirin and KU-60019 (P<0.0001, independent 
sample t-test, no post-hoc test (DC+vehicle vs DC+mirin/DC+KU-60019 at 3 weeks) 
whilst a significant deficit remains in DC+vehicle-treated rats (# = P<0.00012, 
generalized linear mixed models over the whole 6 weeks). (E) Mean error ratio to show 
the number of slips vs. total number of steps in the horizontal ladder walking test also 
returns to normal 3 weeks after treatment with mirin and KU-60019 (P<0.0001, 
independent sample t-test, no post-hoc test (DC+vehicle vs DC+mirin/DC+KU-60019 
at 3 weeks)), with a deficit remaining in DC+vehicle-treated rats (## = P<0.00011, 
linear mixed models over the whole 6 weeks). n = 6 rats/treatment/test, 3 independent 
repeats (total n = 18 rats/treatment/test). 
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Video legends
Video 1. Rotated views of 3D rendered volumes showing pH2Av+ foci in the nuclei of 
central brain neurons from control and Aβ1-42 expressing adult flies. Volumes shown 
in Fig. 1 and Supplementary Fig. 1 were rendered in Fiji-3. Control brain is to the left 
and A1-42-expressing brain to the right. 
Video 2. Genetic reduction of nbs levels maintains neural activity in flies after 10 d of 
Aβ1-42 expression. Flies expressing tandem A1-42 (Speretta et al., 2012) specifically 
in adult neurons for 10 d under the control of Elav-Gal4. Gal80ts was included to 
prevent expression until eclosion. Flies were maintained at 18 °C during development 
and shifted to the permissive temperature of 29°C upon eclosion. Flies in the vial to 
the left are wild-type for nbs; flies to the right are heterozygous for the null nbs2 allele.
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 Figure 1. Targeting the MRN complex is neuroprotective in Drosophila models of neurodegeneration. (A) 
Expression of tAβ1-42 in adult neurons generates DNA double-strand breaks. Projections of central brain 
neurons stained with anti-pH2Av. Control neurons display a single pH2Av+ focus per nucleus corresponding 
to the nucleolus organising region. Multiple neurons expressing Aβ1-42 display large numbers of clustered 
foci (arrowheads). (B) Flies were startled by tapping to the base of a vial and the negative geotaxis climbing 
response quantified as a measure of neural output. Flies expressing (B) Aβ1-42 or (C) Htt.Q128 in adult 
neurons show a rapid decline in climbing ability which is partially suppressed in flies heterozygous for a null 
allele of nbs. Statistical comparisons in (B) by 2-way ANOVA and in (B) by extra sum-of-squares F-test, *** 
indicates p<0.001. (D) When stimulated by vibration, Tau-expressing flies show a rapid decline in the startle 
response which is partially suppressed in nbs-/+ flies. Dashed arrows indicate days of expression required 
for 50% decline in response determined from fitted lines; comparison by 2-tailed t-test. Scale bars in (A) = 
10µm. 
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 Figure 2. Targeting the MRN complex protects against Alzheimer’s disease-relevant phenotypes. (A) 
Expression of A1-42 in clock neurons leads to loss of Per+ cells. In nbs-/+ flies, loss of cells is partially 
prevented (Kruskal-Wallis with Dunn’s post-hoc test; p values and n are indicated). (B) The free-running 
circadian locomotor cycle of control flies is ~24 h but is considerably lengthened when A1-42 is expressed 
in clock neurons indicating weaker rhythmicity in the circadian circuitry. The increase is suppressed in nbs-
/+ flies (CLEAN spectral analysis; comparisons by ANOVA with Tukey’s post-hoc test; p values and n are 
indicated). (C) Exposure of rat hippocampal neurons to A1-42 oligomers in vitro generate double strand 
breaks that can be visualized by staining with anti-H2Ax (red). DNA is visualized with DAPI (blue). (D) 
Quantification of synapsin levels in hippocampal neurons by Western blot. Exposure to A1-42 oligomers 
leads to loss of the pre-synaptic protein, synapsin, which is reversed by the Mre11 inhibitor, mirin (mean ± 
SEM; ANOVA with Tukey’s post-hoc test; P values and n are indicated). Scale bars in (C) = 10µm. 
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 Figure 3. Inhibition of Mre11 prevents RGC apoptosis and stimulates neurite outgrowth after 4 days in 
culture in the presence of inhibitory CNS myelin extracts. (A) Western blot and (B) subsequent densitometry 
to show attenuated levels of anti-H2Ax after treatment with mirin and KU-60019. (C) Mirin or KU-60019 
significantly enhanced RGC survival. (D) Representative images from RGC treated with vehicle, CNTF 
(positive control), mirin and KU-60019. Mirin or KU-60019 treatment (E) increased the mean RGC neurite 
length and (F) % RGC with neurites. n = 3 wells/treatment, 3 independent repeats (total n = 9 
wells/condition). AU = arbitrary units. Comparisons in (B), (C), (E) and (F) by one-way ANOVA with 
Dunnett’s post-hoc test. Scale bars in (D) = 100µm. 
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 Figure 4. Inhibition of Mre11 and ATM prevents RGC apoptosis and stimulates axon regeneration at 24 days 
after optic nerve crush injury. (A) Western blot and (B) subsequent densitometry to show phosphorylation of 
H2Ax (H2Ax) as a marker of DNA damage after optic nerve crush injury (n = 6 retinae/time-point, 3 
independent repeats (total n = 18 retinae/time-point)). (C) Western blot and (D) densitometry to show that 
mirin and KU-60019 significantly suppress optic nerve crush injury-induced H2Ax levels (n = 6 
retinae/time-point, 3 independent repeats (total n = 18 retinae/condition). (E) Representative images and 
(F) quantification of FluoroGold backfilled RGC in retinal wholemounts to demonstrate that mirin and KU-
60019 significantly enhanced RGC survival at 24 days after optic nerve injury (n = 6 retinae/time-point, 3 
independent repeats (total n = 18 retinae/condition). (G) representative images and (H), quantification to 
show that mirin and KU-60019 significantly enhanced RGC axon regeneration as detected by GAP43 
immunoreactivity (n = 6 nerves/condition, 3 independent repeats (total n = 18 nerves/condition). AU = 
arbitrary units. Comparisons in (B), (D), (F) and (H) by one-way ANOVA with Dunnett’s post-hoc test. Scale 
bars in (E) = 50µm and in (G) = 200µm). 
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 Figure 5. Inhibition of Mre11 and ATM reduces the number of DRGN with double strand breaks and the levels 
of H2Ax after DC injury in vivo. (A) Representative images from DC+vehicle, DC+mirin and DC+KU-
60019-treated sections of rat DRGN (n = 6 rats/group, 3 independent repeats; total n = 18 rats/group) 
demonstrating H2Ax (green) localization in the nucleus of DRGN (red). Images are counterstained with 
DAPI (blue) to demarcate the nucleus. (B) Quantification of the frequency of H2Ax+ DRGN sorted by 
different soma size. (C) Quantification of the mean pixel intensity/DRGN in DC+vehicle, DC+mirin and 
DC+KU-60019-treated DRGN. (D) Western blot and (E) subsequent densitometry to demonstrate reduction 
of H2Ax protein levels in DRGN after treatment with mirin and ATM inhibitors.  AU = arbitrary units. 
Comparisons in (C) and (E) by one-way ANOVA with Dunnett’s post-hoc test. n = 6 rats/treatment, 3 
independent repeats (total n = 18 rats/treatment). Scale bars in A = 50µm, insets in A = 10µm. 
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 Figure 6. Intrathecal injection of Mre11 and ATM inhibitors promote significant axon regeneration at 6 weeks 
after spinal cord injury. (A) GAP43+ (green) immunoreactivity was largely absent in DC+vehicle-treated 
groups (Blue = DAPI+ nuclei). However, in DC+mirin and DC+KU-60019-treated rats, enhanced GAP43+ 
immunoreactivity was present in the rostral segment of the spinal cord in beyond the lesion site (#) where a 
large cavity remained. (B) Quantification of the % of axons at different distances rostral to the lesion site 
showed significantly enhanced numbers of GAP43+ regenerating axons at all distances tested after 
treatment with DC+mirin and DC+KU-60019. (n = 10 nerves/condition). Scale bars in (A) = 200µm. 
Comparisons in (B) by one-way ANOVA with Dunnet’s post-hoc test (DC+vehicle vs DC+KU-60019).   
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 Figure 7. Intrathecal injection of Mre11 and ATM inhibitors promotes significant functional repair after spinal 
cord injury. (A) Spike 2 software processed CAP traces from representative sham controls, DC+vehicle, 
DC+mirin and DC+KU-60019-treated rats showing some recovery of dorsum cord potentials in mirin and 
KU-60019-treated rats. Dorsal hemisection between the stimulating and the recording electrodes at the end 
of the experiment ablated CAP traces in all animals demonstrating technical success of the experiment. (B) 
Negative CAP amplitudes were significantly attenuated in DC+vehicle-treated rats but were significantly 
improved in DC+mirin and DC+KU-60019-treated rats (P<0.0001, one-way ANOVA (main effect)). (C) Mean 
CAP area at different stimulation intensities were significantly attenuated in DC+vehicle-treated rats but 
improved significantly in DC+mirin and DC+KU-60019-treated rats (P<0.0001, one-way ANOVA (main 
effect)). (D) Mean tape sensing and removal time are restored to normal 3 weeks after treatment with mirin 
and KU-60019 (P<0.0001, independent sample t-test, no post-hoc test (DC+vehicle vs DC+mirin/DC+KU-
60019 at 3 weeks) whilst a significant deficit remains in DC+vehicle-treated rats (# = P<0.00012, 
generalized linear mixed models over the whole 6 weeks). (E) Mean error ratio to show the number of slips 
vs. total number of steps in the horizontal ladder walking test also returns to normal 3 weeks after 
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treatment with mirin and KU-60019 (P<0.0001, independent sample t-test, no post-hoc test (DC+vehicle vs 
DC+mirin/DC+KU-60019 at 3 weeks)), with a deficit remaining in DC+vehicle-treated rats (## = 
P<0.00011, linear mixed models over the whole 6 weeks). n = 6 rats/treatment/test, 3 independent repeats 
(total n = 18 rats/treatment/test). 
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